Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride more effective for hair growth, but has more side effects than finasteride.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Finasteride improves hair growth in men with androgenetic alopecia.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Lygodii Spora extract may help treat hair loss by blocking a hair loss-related enzyme and promoting hair growth.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Plant extracts may help treat hormone-related hair loss.

Minoxidil and finasteride effectively treat hair loss.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Finasteride effectively treats male hair loss, increasing length and thickness.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Treatments for hair loss vary, but cell-based options may be the future.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

DA-9401 helps protect rat testis from finasteride damage.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

No cure exists for alopecia areata, and treatments are personalized.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

CD101 is highly effective in treating dermatophytosis in guinea pigs.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.